Beranda › Gangguan Depresi Mayor › Arkansas › Little Rock
Uji klinis Gangguan Depresi Mayor di Little Rock, AR
14 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi sekitar Little Rock (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Menerima pesertaFase 3
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Menerima pesertaFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi jauhnya
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Menerima pesertaFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi jauhnya
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Menerima pesertaFase 3
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Menerima pesertaFase 4
- Neurocrine Clinical Site, Bryant · 15 mi jauhnya
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Menerima pesertaFase 3
- SanRo Clinical Research Group, Bryant · 15 mi jauhnya
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Menerima pesertaFase 2
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Menerima pesertaFase 2
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 3
- Neurocrine Clinical Site, Bryant · 15 mi jauhnya
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Menerima pesertaFase 3
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 3
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · 15 mi jauhnya
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Menerima pesertaFase 2
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Menerima pesertaFase 2
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 3
- Neurocrine Clinical Site, Little Rock
Uji klinis Gangguan Depresi Mayor di kota lain
- New York City, NY36 studi
- Boston, MA31 studi
- Atlanta, GA25 studi
- Philadelphia, PA23 studi
- Orlando, FL19 studi
- Miami, FL18 studi
- Chicago, IL17 studi
- Tampa, FL17 studi
- San Diego, CA16 studi
- Houston, TX16 studi
- Austin, TX13 studi
- Las Vegas, NV13 studi
Studi lain di Little Rock
- Skizofrenia19 studi
- Kanker (semua jenis)14 studi
- Leukemia Mieloid Akut13 studi
- Kanker Paru Non-Sel Kecil13 studi
- Obesitas11 studi
- Kanker Endometrium10 studi
- Depresi10 studi
- Diabetes Tipe 210 studi
- Kanker Paru9 studi
- Penyakit Kardiovaskular9 studi
- Kanker Kandung Kemih9 studi
- Gagal Jantung9 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.